Journal Article DZNE-2026-01012

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Locally deployed large language model for real-world lecanemab eligibility pre-screening.

 ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
Wiley Hoboken, NJ

Alzheimer's & dementia / Diagnosis, assessment & disease monitoring 18(3), e70495 () [10.1002/dad2.70495]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The introduction of disease-modifying Alzheimer's therapies requires complex, labor-intensive patient screening. Cloud-based large language models (LLMs) could support this task but are often unsuitable for routine care due to data protection constraints.We evaluated an on-premises, open-weights LLM (gpt-oss-120b) for automated extraction of therapy-relevant variables for lecanemab eligibility from German memory clinic reports. In a two-stage design, LLM-based extraction prompts, a deterministic rule-based extractor, and a shared downstream rule-based classifier were optimized on a development set (n = 97) and evaluated on an independent hold-out set (n = 99), with expert consensus as ground truth.The LLM-based pipeline achieved 94% accuracy and a Cohen's kappa of 0.90 on the hold-out set, significantly surpassing the rule-based comparator (80% accuracy) and demonstrating performance comparable to human experts.A locally deployed, on-premises LLM may assist eligibility screening as a triage support tool, potentially facilitating access to novel therapies without compromising patient data privacy.

Keyword(s): Alzheimer's disease ; disease‐modifying therapy ; large language models ; lecanemab ; secure clinical AI deployment ; treatment eligibility

Classification:

Contributing Institute(s):
  1. Patient Studies (Bonn) (Patient Studies (Bonn))
  2. Clinical Research Platform (CRP) (Clinical Research Platform (CRP))
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2026
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; DOAJ ; OpenAccess ; Article Processing Charges ; Clarivate Analytics Master Journal List ; DEAL Wiley ; DOAJ Seal ; Emerging Sources Citation Index ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Institute Collections > BN DZNE > BN DZNE-Clinical Research Platform (CRP)
Institute Collections > BN DZNE > BN DZNE-Patient Studies (Bonn)
Document types > Articles > Journal Article
Full Text Collection
Public records
Publications Database

 Record created 2026-10-07, last modified 2026-10-20


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)